<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="4" ids="30413">Heme</z:chebi> oxygenase-1 (HMOX-1) is activated by <z:mp ids='MP_0003674'>oxidative stress</z:mp>, and gene responsiveness is reportedly determined by the number of <z:chebi fb="0" ids="47885">dinucleotide</z:chebi> (GT(n)) repeats in its highly polymorphic promoter region. "Short" (S; GT(n)&lt;25) alleles reportedly associate with higher response, lower <z:mp ids='MP_0003674'>oxidative stress</z:mp>, lower risk of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (type 2DM), and better glycemic control and outcome, but data are conflicting </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated GT(n) in type 2DM subjects (<z:hpo ids='HP_0000001'>all</z:hpo> ethnic Chinese) in relation to basal glycemic control, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, and outcome during up to 9 years' follow-up </plain></SENT>
<SENT sid="2" pm="."><plain>Fasting blood from 418 type 2 DM subjects was collected at entry for GT(n) genotyping, glycated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:chebi fb="23" ids="18059">lipids</z:chebi>, and biomarkers of <z:mp ids='MP_0003674'>oxidative stress</z:mp> and <z:chebi fb="11" ids="22586">antioxidants</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>A subset (n=368) was followed for up to 9 years for incident complications or <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>GT(n) genotype distribution was 128, 182, and 108 for, respectively, S/S, S/L, and L/L </plain></SENT>
<SENT sid="5" pm="."><plain>No significant differences in glycemic control, <z:chebi fb="23" ids="18059">lipids</z:chebi>, or <z:mp ids='MP_0003674'>oxidative stress</z:mp> were seen across genotypes </plain></SENT>
<SENT sid="6" pm="."><plain>During follow-up, 168/368 subjects developed complications </plain></SENT>
<SENT sid="7" pm="."><plain>No association was seen with GT(n) </plain></SENT>
<SENT sid="8" pm="."><plain>No difference in plasma HO-1 was seen between genotypes in a small substudy (S/S n=21 vs L/L n=23) </plain></SENT>
<SENT sid="9" pm="."><plain>Glycated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> and lymphocytic DNA damage was higher (p&lt;0.05) at entry in the incident complications group </plain></SENT>
<SENT sid="10" pm="."><plain>No other significant differences were seen in <z:mp ids='MP_0003674'>oxidative stress</z:mp> or <z:chebi fb="11" ids="22586">antioxidants</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>Data do not support the postulated link between HMOX-1 microsatellite polymorphism and type 2 DM or the putative beneficial effect of the S allele on glycemic control, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, or outcome in type 2 DM patients, at least in this particular population </plain></SENT>
</text></document>